Alvimopan Diastereomer 1, identified by its CAS number 342639-35-4, is a chemical compound that belongs to the class of opioid receptor antagonists. It is primarily used in the medical field to manage postoperative ileus, a condition characterized by a temporary cessation of bowel activity following surgery. The compound exhibits selective antagonism at the mu-opioid receptors in the gastrointestinal tract, which helps to restore normal bowel function without affecting analgesia provided by opioids. As a diastereomer, it possesses multiple stereocenters, leading to distinct spatial arrangements that can influence its pharmacological properties and efficacy. Alvimopan is typically administered orally and is characterized by its relatively high affinity for the target receptors, contributing to its therapeutic effects. The compound's safety profile and potential side effects are important considerations in clinical use, particularly in patients with specific health conditions. Overall, Alvimopan Diastereomer 1 represents a significant advancement in the management of postoperative gastrointestinal complications.

Alvimopan Diastereomer 1

342639-35-4: Alvimopan Diastereomer 1, identified by its CAS number 342639-35-4, is a chemical compound that belongs to the class of opioid receptor antagonists. It is primarily used in the medical field to manage postoperative ileus, a condition characterized by a temporary cessation of bowel activity following surgery. The compound exhibits selective antagonism at the mu-opioid receptors in the gastrointestinal tract, which helps to restore normal bowel function without affecting analgesia provided by opioids. As a diastereomer, it possesses multiple stereocenters, leading to distinct spatial arrangements that can influence its pharmacological properties and efficacy. Alvimopan is typically administered orally and is characterized by its relatively high affinity for the target receptors, contributing to its therapeutic effects. The compound's safety profile and potential side effects are important considerations in clinical use, particularly in patients with specific health conditions. Overall, Alvimopan Diastereomer 1 represents a significant advancement in the management of postoperative gastrointestinal complications.

CAS 342639-35-4

Alvimopan Diastereomer 1

Alvimopan (2R, 3R, 4R)-Isomer

Ref: 4Z-A-4316

(2R,3R,4R)-Alvimopan

Ref: TR-A575798

(2R,3R,4R)-Alvimopan

Ref: ST-EA-CP-A127002